Checkpoint inhibition immunotherapy for advanced local and ...

This report suggests that systemic immunotherapy with or without topical interferon is effective in treatment of malignant melanoma of the ...

Advances and challenges in immunotherapy for ... - ScienceDirect.com

Several clinical trials integrating immune checkpoint inhibitors into the standard treatment for locally advanced nasopharyngeal carcinoma have ...

Checkpoint inhibitors | Types of immunotherapy | Cancer Research UK

Ipilimumab (Yervoy) is a checkpoint inhibitor drug that blocks CTLA-4. It is a treatment for advanced melanoma and advanced renal cell cancer. You might ...

Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival ...

Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series. J Immunother Cancer. 2019;7:83. [DOI] ...

a clinical case series | Journal for ImmunoTherapy of Cancer

Download PDF PDF · XML. Short Report. Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series. Loading.

Checkpoint inhibition immunotherapy for advanced local and ...

Background: Herein, we describe the use of systemic immunotherapy for both locally advanced and metastatic conjunctival melanoma.

Checkpoint Inhibitors in Combination With Stereotactic Body ...

... checkpoint inhibitor immunotherapy drugs. JAMA Netw Open ... therapy in patients with metastatic or locally advanced inoperable melanoma.

Introducing Checkpoint Inhibitors Into the Curative Setting of Head ...

... immune checkpoint inhibitors, has ... immunotherapy to curative-intent radiotherapy or chemoradiation therapy in locally advanced HNSCC.

Impact of immune checkpoint inhibitors on the ... - Lung Cancer

To describe the impact of immune checkpoint inhibitors (ICIs) on treatment patterns and survival outcomes in patients with locally advanced or metastatic non- ...

Immune checkpoint inhibitors: recent progress and potential ... - Nature

Pembrolizumab in advanced melanoma patients showed that pre-existing CD8+ T cells in the TME are required for better tumor regression. The ...

Immune checkpoint inhibitors in advanced and recurrent/metastatic ...

In this context, immunotherapy and immune checkpoint inhibitors (ICIs) are particularly likely to play a role in the treatment of cervical ...

a systematic review and individual patient data meta-analysis

Effectiveness of immune checkpoint inhibitors and other treatment modalities in patients with advanced mucosal melanomas: a systematic review ...

Advancements in neoadjuvant immune checkpoint inhibitor therapy ...

The prevalent treatment paradigm for locally advanced head and neck squamous carcinoma (HNSCC) typically entails surgery followed by adjuvant ...

LBA7 Neoadjuvant immune checkpoint inhibition in locally ...

LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study · Background. Neoadjuvant immunotherapy has shown ...

Estimation of the Percentage of US Patients With Cancer Who Are ...

... immunotherapy checkpoint inhibitor drugs, by year. Results Six ... First-line pembrolizumab in cisplatin-ineligible patients with locally advanced ...

Radiation combined with immune checkpoint inhibitors for ...

Radiation combined with immune checkpoint inhibitors for unresectable locally advanced non-small cell lung cancer: synergistic mechanisms ...

Clinical activity of PD-1 inhibition in the treatment of locally ...

Immune checkpoint inhibitors in older adults with melanoma or ... Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy ...

A decade of checkpoint blockade immunotherapy in melanoma

Ten years since the immune checkpoint inhibitor ipilimumab was approved for advanced ... local anti-tumor immune responses. Mechanistic ...

Current status of immune checkpoint inhibition in early-stage NSCLC

In the curative stages of NSCLC, ICI immunotherapy is being studied in both early and locally advanced stages. Here, we will focus on the current status of ...

a new regimen for locally advanced non-small cell lung cancer?

Immune checkpoint inhibitors (ICIs) significantly amplify the systemic anti-tumor effects of radiotherapy (RT). RT not only induces local tumor ...